Skip to main content
. 2010 Nov 21;16(43):5518–5522. doi: 10.3748/wjg.v16.i43.5518

Figure 1.

Figure 1

Serum α-fetoprotein level measured as related to the treatment history. Serum α-fetoprotein (AFP) level was trending up after sorafenib therapy but normalized after sirolimus was initiated. Events are outlined in the Figure. CT: Computed tomography; HCC: Hepatocellular carcinoma.